ShiraTronics develops neuromodulation technology to combat debilitating chronic migraine.
ShiraTronics has raised $66.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
ShiraTronics's investors include Norwest, U.S. Venture Partners, Breakout Ventures, OSF Ventures, Treo Ventures.
ShiraTronics is headquartered in Minneapolis, United States.
ShiraTronics develops neuromodulation technology to combat debilitating chronic migraine.
ShiraTronics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ShiraTronics — Funding & Investors." VCBacked, September 30, 2024, https://www.vcbacked.co/company/shiratronics. Accessed July 19, 2026.
VCBacked. (2024). ShiraTronics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/shiratronics
{{cite web |title=ShiraTronics — Funding & Investors |url=https://www.vcbacked.co/company/shiratronics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated